Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-29 Purchase | 2024-09-03 5:38 pm | Quince Therapeutics Inc. | QNCX | Thye Dirk CEO AND CHIEF MEDICAL OFFICER | 154,500 | $0.69498 | $107,375 | 843,941 (Direct) | View |
| 2024-08-20 Purchase | 2024-08-22 5:51 pm | Quince Therapeutics Inc. | QNCX | Ryan Charles S. PRESIDENT | 48,387 | $0.65 | $31,452 | 122,461 (Direct) | View |
| 2024-08-19 Purchase | 2024-08-21 6:38 pm | Quince Therapeutics Inc. | QNCX | Hannah Brendan CHIEF BUSINESS OFFICER AND COO | 38,924 | $0.62085 | $24,166 | 296,540 (Direct) | View |
| 2023-12-12 Purchase | 2023-12-14 6:21 pm | Quince Therapeutics Inc. | QNCX | Lamond David Director | 67,881 | $1.0199 | $69,233 | 6,686,387 (Indirect Direct) | View |
| 2023-12-05 Purchase | 2023-12-07 6:30 pm | Quince Therapeutics Inc. | QNCX | Lamond David Director | 57,369 | $1.0133 | $58,134 | 4,316,215 (Indirect Direct) | View |
| 2023-11-29 Purchase | 2023-12-01 1:38 pm | Quince Therapeutics Inc. | QNCX | Lamond David Director | 43,134 | $0.94 | $40,546 | 4,258,846 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-18 Option Award | 2025-06-23 08:48 am | 2025-06-18 2030-06-18 | Quince Therapeutics Inc. | QNCX | Hannah Brendan CBO, COO & CCO | 37,736 | $0.125 | 372,012 (Direct) | View |
| 2025-06-18 Option Award | 2025-06-23 08:48 am | N/A N/A | Quince Therapeutics Inc. | QNCX | Hannah Brendan CBO, COO & CCO | 37,736 | $1.2 | 372,012 (Direct) | View |
| 2025-06-18 Option Award | 2025-06-23 08:46 am | 2025-06-18 2030-06-18 | Quince Therapeutics Inc. | QNCX | Ryan Charles S. President | 7,548 | $0.125 | 137,557 (Direct) | View |
| 2025-06-18 Option Award | 2025-06-23 08:46 am | N/A N/A | Quince Therapeutics Inc. | QNCX | Ryan Charles S. President | 7,548 | $1.2 | 137,557 (Direct) | View |
| 2025-06-18 Option Award | 2025-06-23 08:43 am | 2025-06-18 2030-06-18 | Quince Therapeutics Inc. | QNCX | Thye Dirk CEO and CMO | 150,944 | $0.125 | 1,145,829 (Direct) | View |
| 2025-06-18 Option Award | 2025-06-23 08:43 am | N/A N/A | Quince Therapeutics Inc. | QNCX | Thye Dirk CEO and CMO | 150,944 | $1.2 | 1,145,829 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 5:52 pm | N/A 2035-06-04 | Quince Therapeutics Inc. | QNCX | RYAN UNA S Director | 27,000 | $0 | 27,000 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 5:38 pm | N/A 2035-06-04 | Quince Therapeutics Inc. | QNCX | Benatti Luca Director | 27,000 | $0 | 27,000 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 5:36 pm | N/A 2035-06-04 | Quince Therapeutics Inc. | QNCX | Senner Christopher J. Director | 27,000 | $0 | 27,000 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 5:33 pm | N/A 2035-06-04 | Quince Therapeutics Inc. | QNCX | Lamond David Director | 27,000 | $0 | 27,000 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 5:27 pm | N/A 2035-06-04 | Quince Therapeutics Inc. | QNCX | McLoughlin Margaret Director | 27,000 | $0 | 27,000 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 5:14 pm | N/A 2035-06-04 | Quince Therapeutics Inc. | QNCX | Patni Rajiv Director | 27,000 | $0 | 27,000 (Direct) | View |
| 2025-06-04 Option Award | 2025-06-06 5:07 pm | N/A 2035-06-04 | Quince Therapeutics Inc. | QNCX | Bray June Director | 27,000 | $0 | 27,000 (Direct) | View |
| 2025-01-28 Option Award | 2025-02-11 5:44 pm | N/A 2035-01-27 | Quince Therapeutics Inc. | QNCX | Thye Dirk CEO AND CHIEF MEDICAL OFFICER | 1,200,000 | $0 | 1,200,000 (Direct) | View |
| 2025-01-28 Option Award | 2025-02-11 5:43 pm | N/A 2035-01-27 | Quince Therapeutics Inc. | QNCX | Ryan Charles S. PRESIDENT | 300,000 | $0 | 300,000 (Direct) | View |
| 2025-01-28 Option Award | 2025-02-11 5:41 pm | N/A 2035-01-27 | Quince Therapeutics Inc. | QNCX | Hannah Brendan CBO, COO and CCO | 450,000 | $0 | 450,000 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-08 7:33 pm | N/A 2035-01-02 | Quince Therapeutics Inc. | QNCX | McLoughlin Margaret Director | 31,613 | $0 | 31,613 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-08 7:32 pm | N/A 2035-01-02 | Quince Therapeutics Inc. | QNCX | Bray June Director | 30,282 | $0 | 30,282 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-08 7:30 pm | N/A 2035-01-02 | Quince Therapeutics Inc. | QNCX | Lamond David Director | 47,587 | $0 | 47,587 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-08 7:29 pm | N/A 2035-01-02 | Quince Therapeutics Inc. | QNCX | Senner Christopher J. Director | 35,274 | $0 | 35,274 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 9:08 pm | 2025-06-05 2034-06-05 | Quince Therapeutics Inc. | QNCX | Lamond David Director | 27,000 | $0 | 27,000 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 9:04 pm | 2025-06-05 2034-06-05 | Quince Therapeutics Inc. | QNCX | McLoughlin Margaret Director | 27,000 | $0 | 27,000 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 9:03 pm | 2025-06-05 2034-06-05 | Quince Therapeutics Inc. | QNCX | RYAN UNA S Director | 27,000 | $0 | 27,000 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 9:00 pm | 2025-06-05 2034-06-05 | Quince Therapeutics Inc. | QNCX | Senner Christopher J. Director | 27,000 | $0 | 27,000 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 8:59 pm | 2025-06-05 2034-06-05 | Quince Therapeutics Inc. | QNCX | Bray June Director | 27,000 | $0 | 27,000 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 8:57 pm | 2025-06-05 2034-06-05 | Quince Therapeutics Inc. | QNCX | Benatti Luca Director | 27,000 | $0 | 27,000 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 8:55 pm | 2025-06-05 2034-06-05 | Quince Therapeutics Inc. | QNCX | Patni Rajiv Director | 13,500 | $0 | 13,500 (Direct) | View |
| 2024-06-04 Exercise | 2024-06-05 2:37 pm | N/A N/A | Quince Therapeutics Inc. | QNCX | Hannah Brendan CHIEF BUSINESS OFFICER AND COO | 56,061 | $0.55 | 305,055 (Direct) | View |
| 2024-06-04 Exercise | 2024-06-05 2:37 pm | N/A 2032-03-27 | Quince Therapeutics Inc. | QNCX | Hannah Brendan CHIEF BUSINESS OFFICER AND COO | 56,061 | $0 | 305,055 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-15 6:14 pm | N/A 2034-02-15 | Quince Therapeutics Inc. | QNCX | Patni Rajiv Director | 54,000 | $0 | 54,000 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-02 6:02 pm | N/A 2034-01-31 | Quince Therapeutics Inc. | QNCX | Ryan Charles S. PRESIDENT | 145,000 | $0 | 145,000 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-02 5:53 pm | N/A 2034-01-31 | Quince Therapeutics Inc. | QNCX | Hannah Brendan CHIEF BUSINESS OFFICER AND COO | 600,000 | $0 | 600,000 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-02 5:50 pm | N/A 2034-01-31 | Quince Therapeutics Inc. | QNCX | Thye Dirk CEO AND CHIEF MEDICAL OFFICER | 1,500,000 | $0 | 1,500,000 (Direct) | View |
| 2024-01-16 Exercise | 2024-01-17 4:48 pm | N/A N/A | Quince Therapeutics Inc. | QNCX | Thye Dirk CHIEF EXECUTIVE OFFICER | 90,531 | $0.55 | 1,255,302 (Direct) | View |
| 2024-01-16 Exercise | 2024-01-17 4:48 pm | N/A N/A | Quince Therapeutics Inc. | QNCX | Thye Dirk CHIEF EXECUTIVE OFFICER | 149,999 | $0.94 | 1,255,302 (Direct) | View |
| 2024-01-16 Exercise | 2024-01-17 4:48 pm | N/A 2022-03-27 | Quince Therapeutics Inc. | QNCX | Thye Dirk CHIEF EXECUTIVE OFFICER | 240,530 | $0 | 1,255,302 (Direct) | View |
| 2023-10-24 Option Award | 2023-10-26 5:54 pm | N/A 2033-10-23 | Quince Therapeutics Inc. | QNCX | Hannah Brendan Chief Business Officer and COO | 75,000 | $0 | 75,000 (Direct) | View |
| 2023-10-23 Option Award | 2023-10-24 7:46 pm | N/A 2033-10-22 | Quince Therapeutics Inc. | QNCX | Benatti Luca Director | 54,000 | $0 | 54,000 (Direct) | View |
Ownership | 2023-10-24 7:43 pm | N/A N/A | Quince Therapeutics Inc. | QNCX | Benatti Luca Director | 0 | $0 | 80,261 (Direct) | View |